Assetmark, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 103,980 shares of REGN stock, worth $74.3 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

103,980

Previous 95,691 8.66%

Holding current value

$74.3 Million

Previous $101 Million 8.68%

% of portfolio

0.31%

Previous 0.31%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$1024.09 - $1201.76 $8.49 Million - $9.96 Million	8,289 Added 8.66%	103,980 $109 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $1.34 Million - $1.63 Million	1,521 Added 1.62%	95,691 $101 Million
Q1 2024 May 06, 2024	BUY	$902.69 - $993.35 $1.8 Million - $1.99 Million	1,999 Added 2.17%	94,170 $90.6 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $1.2 Million - $1.37 Million	1,552 Added 1.71%	92,171 $81 Million
Q3 2023 Oct 27, 2023	BUY	$692.45 - $844.37 $6.91 Million - $8.43 Million	9,980 Added 12.38%	90,619 $74.6 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $3.91 Million - $4.63 Million	5,581 Added 7.44%	80,639 $57.9 Million
Q1 2023 May 05, 2023	BUY	$680.49 - $826.97 $3.55 Million - $4.31 Million	5,214 Added 7.47%	75,058 $61.7 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $1.84 Million - $2 Million	2,610 Added 3.88%	69,844 $50.4 Million
Q3 2022 Nov 01, 2022	SELL	$573.97 - $724.32 $374,802 - $472,980	-653 Reduced 0.96%	67,234 $46.3 Million
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $2.73 Million - $3.68 Million	-4,981 Reduced 6.84%	67,887 $40.1 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $6.49 Million - $7.61 Million	10,903 Added 17.6%	72,868 $50.9 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $1.1 Million - $1.36 Million	2,032 Added 3.39%	61,965 $39.1 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $579,770 - $687,769	-1,010 Reduced 1.66%	59,933 $36.3 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $1.04 Million - $1.22 Million	-2,192 Reduced 3.47%	60,943 $34 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $2.45 Million - $3.01 Million	5,495 Added 9.53%	63,135 $29.9 Million
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $12.3 Million - $15.6 Million	25,650 Added 80.18%	57,640 $27.8 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $16.8 Million - $20.3 Million	30,843 Added 2689.01%	31,990 $17.9 Million
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $544,131 - $710,243	1,103 Added 2506.82%	1,147 $715,000
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $14,791 - $21,754	44 New	44 $21,000
Q4 2019 Feb 11, 2020	SELL	$274.13 - $376.51 $1.07 Million - $1.46 Million	-3,887 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $1.06 Million - $1.23 Million	3,868 Added 20357.89%	3,887 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $56,924 - $78,815	-190 Reduced 90.91%	19 $6,000
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $21,208 - $25,055	-57 Reduced 21.43%	209 $86,000
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $11,082 - $13,300	33 Added 14.16%	266 $99,000
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $54,426 - $63,319	155 Added 198.72%	233 $94,000
Q2 2018 Aug 01, 2018	BUY	$284.6 - $344.99 $4,269 - $5,174	15 Added 23.81%	78 $27,000
Q1 2018 May 16, 2018	SELL	$315.82 - $393.78 $8,527 - $10,632	-27 Reduced 30.0%	63 $22,000
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $10,400 - $13,628	29 Added 47.54%	90 $34,000
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $2,588 - $3,024	6 Added 10.91%	61 $27,000
Q2 2017 Aug 15, 2017	SELL	N/A	-4 Reduced 6.78%	55 $27,000
Q1 2017 Sep 15, 2017	BUY	N/A	12 Added 25.53%	59 $23,000
Q4 2016 Sep 15, 2017	BUY	N/A	3 Added 6.82%	47 $17,000
Q3 2016 Sep 15, 2017	BUY	N/A	9 Added 25.71%	44 $18,000
Q2 2016 Sep 15, 2017	SELL	N/A	-26 Reduced 42.62%	35 $12,000
Q1 2016 Sep 15, 2017	BUY	N/A	39 Added 177.27%	61 $22,000
Q4 2015 Sep 15, 2017	BUY	N/A	22	22 $12,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account